Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following events in September 2019:

 
Wells Fargo Healthcare Conference
Date:  Wednesday, September 4, 2019              
Presentation Time:  4:10 p.m. EDT
Location:  Boston, Massachusetts, USA
Webcast:  Celyad’s website, under Events & Webcasts section
 
CAR-TCR Summit
Date:  September 10 – 13, 2019            
Location:  Boston, Massachusetts, USA
 
International Conference on Lymphocyte Engineering (ICLE)
Date:  September 13 – 15, 2019            
Location:  London, United Kingdom
 
KBC Annual Healthcare Conference
Date:  Thursday, September 26, 2019
Location:  Brussels, Belgium

Download press release(s)

Press release

68.82 Ko

Communiqué de presse

84.74 Ko

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing P...

Next News

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing P...